(Q42996182)

12 November 2017

Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate (English)

1 reference

12 November 2017

1 reference

0 references

1 reference

Baumert TF

1

1 reference

12 November 2017

Vergalla J

2

1 reference

12 November 2017

Satoi J

3

1 reference

12 November 2017

Thomson M

4

1 reference

12 November 2017

Lechmann M

5

1 reference

12 November 2017

Herion D

6

1 reference

12 November 2017

Greenberg HB

7

1 reference

12 November 2017

Ito S

8

1 reference

12 November 2017

Liang TJ

9

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

12 November 2017

1 reference

12 November 2017

117

1 reference

12 November 2017

1397-1407

1 reference

12 November 2017

6

1 reference

The molecular virology of hepatitis C.

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Vaccines to prevent viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Vaccination of chimpanzees against infection by the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Limited humoral immunity in hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

DNA vaccines and viral hepatitis: are we going around in circles?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

Hepatitis C virus structural proteins assemble into viruslike particles in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

7 January 2021

Expression and self-assembly of empty virus-like particles of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

7 January 2021

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970290-8

7 January 2021

10.1016/S0016-5085(99)70290-8

Identifiers

DOI

1 reference

release_kt4qd2m4qzar7bfgxhap6etov4

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kt4qd2m4qzar7bfgxhap6etov4

24 November 2022

mapped directly with Wikidata item

1 reference